User banner image
User avatar
  • admin

Posts

SweetWater Brewing Company and Georgia Aquarium Celebrate Third Year of Partnership with Limited Edition Aquarium-Themed Can Art for OG IPA

ATLANTA, March 20, 2025 (GLOBE NEWSWIRE) — SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in Georgia and the Southeast and a...

Halal Cosmetics Forecast Report 2025: Global Market to Surpass $135 Billion by 2033, Driven by Focus on Natural Ingredients, Sustainability, and Ethical Manufacturing Across Muslims and Non-Muslims

Dublin, March 20, 2025 (GLOBE NEWSWIRE) — The “Halal Cosmetics Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has been...

Liposuction Surgery Devices Market Growth Report and Company Analysis 2025-2033 Featuring SOLTA MEDICAL, InMode, Genesis Biosystems, Hologic, Apyx Medical, Cynosure, YOLO Medical, and Sciton

Dublin, March 20, 2025 (GLOBE NEWSWIRE) — The “Liposuction Surgery Devices Market Size and Share Analysis – Growth Trends and Forecast Report 2025-2033” report has...

Better-for-You Snacks Market Set to Reach USD 54.4 Billion by 2035 | Future Market Insights, Inc.

The better-for-you snacks market in the USA is growing steadily as consumers prioritize healthy eating. Demand for organic, non-GMO, and protein-rich options is driving innovation,...

Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction

BOSTON, March 20, 2025 (GLOBE NEWSWIRE) — Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on cardiovascular diseases with high unmet need by developing a range...

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic...

Corvus Pharmaceuticals Announces Presentation of Additional Data from the Phase 1/1b Clinical Trial of Soquelitinib for Patients with T Cell Lymphoma

Data to be presented in oral session and poster at the 16th Annual T-Cell Lymphoma Forum SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE)...

Reflect Scientific Inc. Reports Strong Revenue Growth in 2024

OREM, Utah, March 20, 2025 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (OTC: RSCF), a leading provider of cryogenic cooling and laboratory equipment, is pleased to...

VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

BRIDGEWATER, N.J., March 20, 2025 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated...

realme 14 5G Unveiled: The Ultimate Gaming Dominator with Futuristic Mecha Design

KUALA LUMPUR, Malaysia, March 20, 2025 /PRNewswire/ — realme, a tech brand that better understands young users, is proud to unveil the realme 14 Series...